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ABSTRACT COMMD1 deficiency results in defective copper homeostasis, but the mecha-
nism for this has remained elusive. Here we report that COMMD1 is directly linked to early 
endosomes through its interaction with a protein complex containing CCDC22, CCDC93, and 
C16orf62. This COMMD/CCDC22/CCDC93 (CCC) complex interacts with the multisubunit 
WASH complex, an evolutionarily conserved system, which is required for endosomal deposi-
tion of F-actin and cargo trafficking in conjunction with the retromer. Interactions between 
the WASH complex subunit FAM21, and the carboxyl-terminal ends of CCDC22 and CCDC93 
are responsible for CCC complex recruitment to endosomes. We show that depletion of CCC 
complex components leads to lack of copper-dependent movement of the copper trans-
porter ATP7A from endosomes, resulting in intracellular copper accumulation and modest 
alterations in copper homeostasis in humans with CCDC22 mutations. This work provides a 
mechanistic explanation for the role of COMMD1 in copper homeostasis and uncovers addi-
tional genes involved in the regulation of copper transporter recycling.
INTRODUCTION
Copper is an essential transition metal that is required for the enzy-
matic activity of several vital proteins and pathways. However, given 
the high reactivity of copper, its levels are carefully regulated, and 
consequently, alterations in pathways that handle copper can result 
in disease states. In humans, mutations in the copper transporters 
are the main causes of disorders of copper metabolism (Wang et al., 
2011), including copper deficiency, due to mutations in ATP7A, and 
copper accumulation, also known as Wilson’s disease, which is 
due to mutations in the closely related transporter ATP7B. A key 
functional aspect of ATP7A and ATP7B is their copper-responsive 
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endosomes. In the absence of the CCC complex or its recruitment 
to endosomes, ATP7A is mislocalized and does not traffic in re-
sponse to copper availability, resulting in altered copper handling.
RESULTS
Loss of CCDC22 or COMMD1 affects copper-dependent 
ATP7A trafficking
ATP7A is dynamically recycled between the TGN, where it is present 
when copper availability is low, and cytosolic vesicles, where it is 
redistributed under high copper conditions. From these cytosolic 
vesicles, ATP7A then reaches the plasma membrane and is respon-
sible for cellular copper efflux (Wang et al., 2011). Whereas 
COMMD1 deficiency leads to copper accumulation (van de Sluis 
et al., 2002; Burstein et al., 2004; Vonk et al., 2011; Materia et al., 
2012), a possible role for CCDC22 in copper handling has not been 
previously studied.
We first examined the subcellular distribution of ATP7A using fi-
broblasts derived from a patient with a recently described point mu-
tation in CCDC22 (c.49A>G/p.T17A). This mutation results in abnor-
mal mRNA splicing, reduced protein expression, and impaired 
CCDC22–COMMD1 protein interactions (Voineagu et al., 2012; 
Starokadomskyy et al., 2013). Whereas control fibroblasts demon-
strated dramatic redistribution of ATP7A in response to copper 
availability, CCDC22 T17A fibroblasts had lost the normal dynamic 
redistribution upon changes in copper availability (Figure 1A and 
Supplemental Figure S1). These cells displayed a peripheral distri-
bution of ATP7A in large vesicles irrespective of copper levels and 
lacked the TGN localization of ATP7A upon copper deprivation 
(Figure 1, A and B). These alterations in ATP7A distribution were mir-
rored by COMMD1 deficiency in control fibroblasts after small inter-
fering RNA (siRNA)–mediated silencing (Figure 1C). Consistent with 
these alterations in ATP7A trafficking, CCDC22 deficiency led to in-
creased intracellular copper levels (Figure 1D), akin to what has been 
reported for COMMD1 deficiency (Burstein et al., 2004; Spee et al., 
2007). However, patients with the CCDC22 T17A mutation did not 
display overt clinical signs of copper toxicosis, nor did they display 
biochemical evidence of copper overload, which is primarily deter-
mined in clinical settings by increased urinary copper excretion over 
24 h (Figure 1, E and F). Instead, some affected individuals had ele-
vated serum copper and serum ceruloplasmin concentrations, re-
sembling the phenotype of the liver-specific Commd1-knockout 
mouse (Vonk et al., 2011) and the elevated ceruloplasmin levels of 
Bedlington terriers with COMMD1 mutations (Su et al., 1982). Taken 
together, these findings indicate an important role for both COMMD1 
and CCDC22 in copper homeostasis and ATP7A trafficking.
Identification of the CCC complex
We recently reported that CCDC22 can bind to all 10 members of 
the COMMD protein family (Starokadomskyy et al., 2013). This anal-
ysis not only revealed the interaction between CCDC22 and 
COMMD proteins, but it also showed that CCDC22 bound to 
CCDC93, a protein that shares similar domain organization (Schou 
et al., 2014). Another partner found in this analysis was C16orf62, a 
protein whose function is also unknown. Of interest, all three pro-
teins display a similar range of evolutionary conservation (Supple-
mental Figure S2) and are predicted to belong to an evolutionary 
conserved module that coevolved with the WASH complex (Li et al., 
2014b).
Given that CCDC93 was also identified in two prior TAP screens 
using COMMD9 and COMMD10 as baits, we speculated that these 
proteins associate to form what we refer to as the CCC complex. 
This possibility was examined directly by coimmunoprecipitation 
trafficking between the trans-Golgi network (TGN) and vesicles in 
the cell periphery, which is the subject of significant study (Wang 
et al., 2011).
In addition to these genetic disorders in humans, several Mende-
lian copper metabolic disorders in animals have provided critical 
clues regarding copper homeostatic mechanisms. Among these is 
an autosomal recessive form of copper accumulation affecting some 
purebred dogs, most notably Bedlington terriers (van de Sluis et al., 
2002), which is characterized by chronic hepatitis and cirrhosis, mim-
icking several aspects of Wilson’s disease. This disorder is due to the 
deletion of exon 2 of the copper metabolism MURR1 domain–con-
taining 1 (COMMD1) gene. COMMD1 is the founding member 
of the COMMD protein family, which includes 10 highly conserved 
factors present in most eukaryotes (Burstein et al., 2005) that are 
also linked to proinflammatory signaling (Maine et al., 2007; 
Starokadomskyy et al., 2013; Li et al., 2014a), hypoxia adaptation 
(van de Sluis et al., 2007, 2010), and electrolyte transport (Biasio 
et al., 2004; Drevillon et al., 2011). With regard to copper metabo-
lism, COMMD1 has been reported to bind to both ATP7A and 
ATP7B, but the specific regulation that it provides has not been con-
clusively elucidated (Tao et al., 2003; Vonk et al., 2011; Materia et al., 
2012). According to one report, the retrograde transport of ATP7B 
from peripheral endosomal vesicles back to the TGN in response to 
copper deprivation is deregulated in the absence of COMMD1 
(Miyayama et al., 2010). However, the precise mechanism by which 
COMMD1 may affect ATP7A/7B trafficking has remained elusive 
(Weiss et al., 2008; Miyayama et al., 2010; Materia et al., 2012).
Recent studies have shown that movement of the copper trans-
porter ATP7A from endosomal vesicles to the plasma membrane 
(Steinberg et al., 2013) is dependent on sorting nexin 27 (SNX27) 
acting in conjunction with the retromer complex. This multisubunit 
protein complex was initially identified in yeast (Seaman et al., 1998) 
and has been subsequently identified in a wide range of organisms, 
including mammals (Haft et al., 2000). Retromer consists of a cargo 
selection complex comprising a trimer of VPS26, VPS29, and VPS35, 
which acts in concert with other cellular proteins to orchestrate the 
movement of selected endosomal cargos. This is accomplished first 
through the recruitment of sorting nexins (SNX1, 2, 5, and 6), which 
facilitate membrane deformation and tubulation for the generation 
of the nascent cargo-loaded vesicles (Cullen and Korswagen, 2012). 
In addition, retromer recruits the Wiskott–Aldrich syndrome protein 
and SCAR homologue (WASH) complex to endosomes (Gomez and 
Billadeau, 2009; Harbour et al., 2012). This pentameric complex, 
containing WASH, FAM21, Strumpellin, SWIP, and CCDC53, pro-
motes branched F-actin deposition on endosomes by activating the 
ubiquitously expressed Arp2/3 complex (Derivery et al., 2009; 
Gomez and Billadeau, 2009). This activity facilitates receptor traf-
ficking and is required to maintain segregation of endosomal sort-
ing domains (Derivery et al., 2009; Gomez and Billadeau, 2009; 
Gomez et al., 2012; Harbour et al., 2010; Zech et al., 2011).
Recently we found that COMMD1 and members of the COMMD 
protein family bind to coiled-coil domain–containing protein 22 
(CCDC22), a poorly understood factor whose encoding gene is mu-
tated in some families with X-linked intellectual disability (Voineagu 
et al., 2012; Starokadomskyy et al., 2013; Kolanczyk et al., 2014). Of 
interest, CCDC22 was recently reported to interact with FAM21, a 
WASH complex component (Harbour et al., 2012), but the func-
tional significance of this interaction has not been investigated. In 
this study, we report that COMMD1 forms a complex containing 
CCDC22, as well as the previously uncharacterized factors CCDC93 
and C16orf62. This complex, referred to hereafter as the CCC 
(COMMD/CCDC22/CCDC93) complex, is recruited by FAM21 to 
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(Supplemental Figure S6A). Furthermore, all 
10 human COMMD family members fused 
to glutathione S-transferase (GST) uniformly 
coprecipitated endogenous CCDC93 (Sup-
plemental Figure S3A). Taken together, the 
interaction experiments validated the no-
tion that these factors form a multiprotein 
complex.
CCC subunits stabilize expression 
of components of the complex
For many stable complexes, including 
WASH and retromer, expression of individ-
ual subunits is required to stabilize other 
components within the complex. We exam-
ined this notion first in fibroblasts from pa-
tients with the CCDC22 T17A mutation and 
found that in addition to the expected re-
duction in CCDC22 expression, the levels of 
CCDC93 were drastically reduced in these 
cells (Figure 2D). This phenomenon was re-
capitulated by RNA interference–mediated 
silencing of either CCDC22 or CCDC93 
(Supplemental Figure S3B) and could not be 
explained by corresponding mRNA changes 
(Supplemental Figure S3C), consistent with 
a posttranscriptional event. In addition, de-
ficiency of Commd1 in mouse embryo fibro-
blasts (MEFs) also led to reduced expression 
of Ccdc22 and Ccdc93 (Figure 2E). On the 
other hand, COMMD1 expression was not 
affected by siRNA of either CCDC22 or 
CCDC93 (Supplemental Figure S3B) or by 
the CCDC22 T17A mutation (Starokadom-
skyy et al., 2013). With regard to C16orf62, 
its expression was minimally affected in 
Commd1−/− MEFs but was more noticeably 
reduced in CCDC22 T17A fibroblasts (Figure 
2, D and E); conversely, silencing of C16orf62 
did not affect expression of other CCC sub-
units (Supplemental Figure S4C), which sug-
gests that this subunit is less vital to the sta-
bility of the complex.
Organization of the CCC complex
Next we evaluated the protein domains in 
CCDC22 and CCDC93 that are required for 
their interaction. As depicted in Figure 2, F 
and G, both CCDC93 and CCDC22 have a 
shared amino- terminal domain belonging 
to the NDC80 and NUF2-calponin homology domain (NN-CH), 
followed by coiled-coil (CC) domains (Schou et al., 2014). On ex-
pressing domain truncation mutants of CCDC93, we identified 
that the NN-CH and the middle CC domain of CCDC93 (1–430) 
were required for CCDC22 binding, although some binding was 
possible to the CC region alone (207–431; Figure 2F). Conversely, 
the NN-CH region of CCDC22 and an extension just before its 
carboxy-terminal CC domain (1–447) was required for CCDC93 
binding (Figure 2G). Moreover, recombinant CCDC22 1–447 puri-
fied from Escherichia coli was able to coprecipitate recombinant 
CCDC93 1-430 in vitro, consistent with a direct interaction through 
their N-terminal regions (Supplemental Figure S4A).
experiments. First, endogenous CCDC22 readily coprecipitated en-
dogenous CCDC93 and C16orf62, and, conversely, the immuno-
precipitation of these proteins also brought down the other two 
components of this complex (Figure 2A). We next examined whether 
COMMD proteins also interacted with these newly identified part-
ners of CCDC22. First, immunoprecipitation of endogenous 
CCDC93 resulted in the coprecipitation of endogenous COMMD1 
and COMMD6 but not IKK1 (Figure 2B). Second, endogenous 
COMMD1 coprecipitated endogenous C16orf62 and CCDC93 but 
not IKK1 (Figure 2C). The reciprocal interactions between CCDC22, 
CCDC93, C16orf62, and COMMD1 could be readily demonstrated 
using a coiled-coil protein (NEMO) as an additional negative control 
FIGURE 1: Regulation of ATP7A trafficking by CCDC22 and COMMD1. (A, B) ATP7A localization 
in response to copper was assessed in control and CCDC22 T17A fibroblasts via immuno­
fluorescence staining for endogenous ATP7A (red) and GM130 (green). (A) Representative 
images. (B) Quantification of ATP7A distribution pattern in >50 cells/group. The ATP7A 
distribution observed in CCDC22 T17A fibroblasts was statistically different from the control line 
(p < 0.001). Scale bar, 20 μm. (C) ATP7A localization in control dermal fibroblasts was examined 
as before. Cells were transfected with either control siRNA duplexes or siRNA targeting 
COMMD1. After copper treatments, cells were stained for ATP7A (red) and nuclei (blue) and 
imaged by confocal microscopy. (D) Increased levels of cellular Cu were noted after siRNA 
silencing of CCDC22. (E) Pedigree of a kindred affected by a CCDC22 (c.49A>G/p.T17A) 
mutation. (F) The concentration of copper (Cu) in serum and urine was determined in selected 
probands of this kindred. Similarly, serum ceruloplasmin concentration (CP) and urinary excretion 
of copper over 24 h (Cu/24h) were also ascertained when possible. Normal value ranges are 
indicated at the top of the table. Abnormal values are marked in red.
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coprecipitation between CCDC22 and 
C16orf62 was affected by CCDC93 defi-
ciency, suggesting interdependence be-
tween these factors in their ability to form a 
larger complex. Finally, binding of C16orf62 
to CCDC22 or CCDC93 could not be 
mapped to a single domain (Figure 2, F 
and G), nor did C16orf62 silencing impair 
CCDC93 binding with CCDC22 and 
COMMD1 (Supplemental Figure S4C), sug-
gesting that CCDC22/CCDC93/COMMD1 
interactions are not dependent on C16orf62. 
Taken together, these data indicated that 
CCDC22–CCDC93 interactions are directly 
mediated by their amino termini, and simi-
larly, the interactions between COMMD1 
and CCDC22 are likely direct and indepen-
dent of other components. On the other 
hand, C16orf62 likely requires extensive in-
teractions with both CCDC22 and CCDC93 
to be assembled within the CCC complex.
The CCC and WASH complexes 
interact with each other
To gain further insight into the function of 
the CCC complex, protein–protein interac-
tion maps were developed using data 
deposited in the National Center for Bio-
technology Information (NCBI). This analysis 
indicated that the predicted interactome for 
the human CCC complex includes com-
plexes involved in vesicular sorting, such as 
the WASH complex, exocyst, and BLOC-1 
(Figure 3A). Remarkably similar results were 
obtained when examining protein–protein 
interaction networks in Drosophila (Supple-
mental Figure S5).
The possible interplay between the 
CCC and WASH complexes is in agreement 
with a recent report in which CCDC22 and 
CCDC93 were noted to interact with the 
WASH complex subunit FAM21 (Harbour 
et al., 2012). Moreover, the retromer com-
plex, which is responsible for recruiting and 
activating WASH, was recently implicated 
in ATP7A sorting (Steinberg et al., 2013). To 
examine these possible interactions, we 
first immunoprecipitated FAM21 or WASH 
and found that each readily coprecipitated 
endogenous CCC components (C16orf62, 
CCDC93, and CCDC22; Figure 3B). Con-
versely, immunoprecipitation of endoge-
nous CCC components also coprecipitated 
endogenous WASH (Supplemental Figure 
S6A) and FAM21 (Supplemental Figure 
S6B). Of interest, retromer did not appear 
to be required for WASH–CCC interactions, as demonstrated by 
the fact that FAM21 could precipitate CCC components to the 
same extent in control and VPS35-deficient cells (Supplemental 
Figure S6C).
Next we examined whether the WASH complex played any role 
in the stability of the CCC complex. In this regard, we noted that 
The domain analysis also indicated that the binding of CCDC22 
to COMMD1 was separable from its interaction to CCDC93 (amino 
acids 1–321 vs. 1–447; Figure 2G). This suggested that CCDC93 
could be dispensable for CCDC22–COMMD1 binding, and, in-
deed, CCDC22 interactions with COMMD1 were not affected by 
CCDC93 silencing (Supplemental Figure S4B). On the other hand, 
FIGURE 2: Discovery of the COMMD1–CCDC22 interactome. (A) Coimmunoprecipitation of 
endogenous CCDC22, CCDC93, and C16orf62 in HEK293T cell lysates confirm their 
interactions. (B) Endogenous CCDC93 coimmunoprecipitates with COMMD1 and COMMD6 in 
HEK293T cell lysates. (C) Endogenous COMMD1 coimmunoprecipitates with C16orf62 and 
CCDC93 in HEK 293 cell lysates. (D) Expression of CCC complex subunits was examined by 
immunoblotting in CCDC22 T17A fibroblasts. (E) Expression of CCC complex subunits was 
examined by immunoblotting in Commd1­deficient fibroblasts (Commd1−/−) and its isogenic 
control (Commd1F/F). (F, G) Domain organization of CCDC93 and CCDC22. Truncation 
mutants of CCDC93 (F) or CCDC22 (G) were expressed in HEK293T cells and subsequently 
immunoprecipitated from cell lysates to assess their ability to interact with CCDC22, CCDC93, 
COMMD1, and C16orf62, as indicated. Glyceraldehyde 3­phosphate dehydrogenase (GAPDH) 
and NEMO served as specificity controls. The asterisk in G denotes bands resulting from the 
hemagglutinin (HA) immunoblot and are not the GAPDH band, which migrates faster.
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components, namely CCDC93 and C16orf62 (Figure 3C and Sup-
plemental Figure S7C). COMMD1-containing cytosolic foci demon-
strated colocalization with WASH and the retromer subunit VPS35 
(Figure 3D and Supplemental Figure S7C). Moreover, COMMD1 
foci colocalized with the early endosomal marker RUFY1 and were 
closely juxtaposed to EEA1+ foci on endomembranes (Supplemen-
tal Figure S7, B and C). This finding closely resembles the localiza-
tion of the WASH complex itself (Gomez and Billadeau, 2009). These 
structures were clearly distinct from very early endocytic vesicles 
containing APPL1 and did not colocalize with lysosomal (LAMP1) or 
TGN (TGN46) markers (Supplemental Figure S7, B and C). Transient 
expression of fluorescently tagged CCC complex proteins revealed 
simultaneous colocalization for COMMD1, CCDC22, and CCDC93, 
as well as for COMMD1, C16orf62, and CCDC93 (Supplemental 
Figure S7D). Taken together, these data indicate that the CCC 
Wash deficiency in MEFs did not impair the expression of CCC com-
plex subunits or their ability to coimmunoprecipitate (Supplemental 
Figure S6D), and we observed a similar finding after silencing FAM21 
in HeLa cells (Supplemental Figure S6E). These data suggested that 
despite their interactions, the CCC and WASH complexes are dis-
tinct and independent.
CCC complex components colocalize with WASH and 
retromer in the early endosome
The WASH complex is known to localize primarily to early endo-
somes, where it is recruited by retromer. In view of this, we next 
evaluated whether the CCC complex is similarly recruited to early 
endosomes. First, using a highly specific monoclonal antibody 
against COMMD1 (Supplemental Figure S7A), we found that this 
protein has a high degree of colocalization with other CCC complex 
FIGURE 3: Interaction and colocalization of the CCC and WASH complexes. (A) Interaction map between CCC 
complex components and other cellular complexes were drawn using data extracted from NCBI. Intracomplex 
interactions, where useful, are also indicated. Human studies are depicted, and interactions identified in this study 
are depicted in red. (B) Coimmunoprecipitation of endogenous CCC subunits (CCDC22, CCDC93, and C16orf62) 
with the WASH components (FAM21 and WASH) was noted using HeLa cell lysates. (C) Colocalization of 
endogenous COMMD1 (green) and CCDC93 (red) or C16orf62 (red) was examined by immunostaining in 
HeLa cells. Scale bar, 5 μm. (D) Colocalization of endogenous COMMD1 (green) with WASH (red, top), and the 
retromer subunit VPS35 (red, bottom) was examined by immunofluorescence staining of HeLa cells. Scale bar, 
5 μm.
96 | C. A. Phillips-Krawczak, A. Singla, et al. Molecular Biology of the Cell
(which results in deficiency of both CCDC93 and CCDC22) led to 
altered ATP7A recycling in response to copper availability, which 
demonstrated peripheral redistribution of the transporter and loss 
of its TGN localization upon copper deprivation, a finding that was 
also seen upon VPS35 silencing (Figure 4, A and B).
Recently it was reported that retromer, in conjunction with 
SNX27, also regulates the delivery of ATP7A from endosomes to the 
plasma membrane (Steinberg et al., 2013). Using biotinylation to 
mark plasma membrane proteins, we found that VPS35 deficiency, 
and to a lesser extent CCDC93 deficiency, resulted in decreased 
complex localizes to a subcompartment of the early endosome that 
is enriched in retromer and WASH.
The CCC complex regulates ATP7A trafficking
Taken together, our experiments indicated that COMMD1, CCDC22, 
CCDC93, and C16orf62 interact to form a higher-order stable com-
plex that colocalizes with retromer and WASH on early endosomes. 
In view of this, we tested whether other components of this complex 
also regulate ATP7A trafficking, akin to the effects noted for CCDC22 
and COMMD1 (Figure 1). Stable silencing of CCDC93 in HeLa cells 
FIGURE 4: Depletion of CCC complex components impairs trafficking of ATP7A and TGN46. (A) The indicated HeLa 
control and CCDC93­ or VPS35­knockdown cell lines (sh, short hairpin against the indicated target) were maintained in 
high­copper conditions or transitioned to low copper as indicated in Materials and Methods. The cells were 
subsequently stained for ATP7A (red) and DNA (blue) and imaged by confocal fluorescence microscopy. Scale bar, 
20 μm. (B) Quantification of ATP7A localization in the indicated knockdown cell lines was examined (>50 cells/group 
were scored). The ATP7A distribution observed in shCCDC93 and shVPS35 was statistically different from the control 
line (p < 0.001). (C) Plasma membrane expression of ATP7A was determined in the same cell lines after high­ and 
low­copper conditions using biotinylation as described in Materials and Methods. N­Cadherin served as a loading 
control. (D) The indicated HeLa knockdown cell lines were stained for GM130 (green), TGN46 (red), F­actin (dark blue), 
and DNA (light blue) and imaged by confocal microscopy. Scale bar, 20 μm. (E) TGN46 localization was quantified in the 
indicated HeLa knockdown lines (>50 cells/group were scored). The TGN46 distribution observed in shCCDC22, 
shC16orf62, and shVPS35 was statistically different from that in the control line (p < 0.001).
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mediating those interactions. To that end, we performed domain-
mapping experiments to identify the domains in CCDC93 and 
CCDC22 responsible for FAM21 binding. As shown in Figure 5D, 
two regions in CCDC93 demonstrated specific binding to FAM21: a 
middle region encompassing amino acids 207–431, and its carboxyl-
terminal end spanning amino acids 411–631. A similar analysis with 
CCDC22 (Figure 5E) also indicated that two regions bound to 
FAM21, namely amino acids 1–447 and the carboxyl-terminal region 
encompassed by 321–627. The specificity of binding between these 
domains and FAM21 was further validated by demonstrating that 
these constructs do not coprecipitate with NEMO, an unrelated 
coiled-coil protein (Supplemental Figure S11, A and B). After ac-
counting for the ability of discrete domains to form CCDC22/
CCDC93 heterodimers (namely CCDC93 207–431 and CCDC22 
1–447; Figure 2, G and H), these data indicated that the carboxyl-
terminal ends of CCDC22 and CCDC93 could interact with FAM21.
We next turned our attention to FAM21 itself. This protein has an 
amino-terminal “head” domain that is responsible for its incorpora-
tion into the WASH complex and a long, unstructured tail that con-
tains multiple leucine–phenylalanine acidic motifs (Figure 6A; Jia 
et al., 2012). Distinct regions within this tail are believed to mediate 
specific interactions. Domain mapping experiments using previ-
ously described suppression/reexpression vectors (Derivery et al., 
2009; Gomez and Billadeau, 2009) expressing different regions of 
FAM21 indicated that the amino-terminal “head” of FAM21, en-
compassing amino acids 1–356, could not bind to the CCC complex 
(Figure 6B, left). Instead, the FAM21 tail (356-end) was sufficient for 
binding to the CCC complex, consistent with a prior report pertain-
ing to CCDC22 and CCDC93 (Harbour et al., 2012). Moreover, the 
FAM21 tail had to encompass its middle region for CCC complex 
interaction and could not be sustained by its carboxyl-terminal end 
(742-end; Figure 6B, right). Using in vitro binding, we found that 
recombinant maltose-binding protein (MBP)–tagged CCDC93 
(amino acids 411–631) could bind to a specific region of the FAM21 
tail contained in recombinant GST-FAM21 356–600 (Figure 6C) but 
did not interact with more-carboxy-terminal regions of the tail en-
compassed in either amino acids 601–900 or 901–1341. Further 
truncation mutants of the CCDC93 carboxyl terminus revealed that 
a construct containing amino acids 448–631, but not 544–631, was 
capable of directly binding the GST-FAM21 356–600 fragment 
(Figure 6D). This interaction was recapitulated using surface plas-
mon resonance, which demonstrated a dose-dependent increase in 
the binding of CCDC93 (448–631) with immobilized GST-FAM21 
356–600 with a mean dissociation constant of 0.3–0.6 nM (Figure 
6E). This FAM21 fragment did not interact with MBP (Supplemental 
Figure S10B). Taken together, these data indicate that the C-termi-
nus of CCDC93 can make a direct and high-affinity interaction with 
the N-terminal tail region of FAM21.
Finally, we assessed the functional consequence of these interac-
tions for the ability of CCDC93 to regulate the trafficking of ATP7A. 
Reintroduction of CCDC93 into HeLa deficient cells (after CRISPR-
mediated deletion) demonstrated that only full-length CCDC93 res-
cued the localization of COMMD1 back to cytosolic puncta and was 
similarly able to restore the TGN localization of ATP7A under low-
copper conditions. Of significance, cells expressing the truncated 
version of CCDC93 unable to bind FAM21 were unable to rescue 
the TGN localization of ATP7A or the punctate accumulation of 
COMMD1 (Figure 7, A and B, and Supplemental Figure S10C).
DISCUSSION
The role of COMMD1 in mammalian copper homeostasis has been 
appreciated for more than a decade (van de Sluis et al., 2002), but 
levels of ATP7A at the membrane during high copper exposure 
(Figure 4C). Furthermore, retromer deficiency can result in inappro-
priate sorting of endosomal cargo to lysosomes, leading to overall 
reductions in protein expression. However, whereas VPS35-deficient 
cells were depleted in ATP7A (Supplemental Figure S8, C and D) in 
agreement with previous results (Steinberg et al., 2013), deficiency 
of CCC components did not affect overall levels of ATP7A in a vari-
ety of models (Supplemental Figure S8, A–C).
In addition to ATP7A, retromer and WASH regulate the retro-
grade transport to the TGN of a variety of endosomal cargo, includ-
ing TGN46 (Hao et al., 2013). Under control conditions, we found 
that this protein was localized in close proximity to the cis-Golgi 
marker GM130 as expected; however, upon silencing of CCC com-
plex components or the retromer subunit VPS35, TGN46 was dif-
fusely localized in peripheral cytosolic vesicles (Figure 4, D and E). 
Thus loss of the CCC complex phenocopies retromer depletion 
and demonstrates an important role for the CCC complex in the 
trafficking of retromer cargo such as ATP7A and TGN46.
FAM21 is required for endosomal recruitment 
of the CCC complex
Given the interaction and colocalization of the CCC and WASH 
complexes, we examined whether their endosomal localization were 
interrelated. In this regard, we noted that stable silencing of FAM21 
in HeLa cells (shFAM21) drastically reduced cytosolic puncta for 
COMMD1, as well as for the CCC complex components CCDC93 
and C16orf62 (Figure 5A and Supplemental Figure S9A). In contrast 
to this result, loss of Wash in mouse fibroblasts did not abolish 
COMMD1 endosomal localization (Supplemental Figure S9B). In-
stead of discrete puncta, COMMD1 localized to collapsed endo-
somal structures, which retained FAM21 localization, as previously 
reported (Gomez et al., 2012). Furthermore, silencing of VPS35, a 
subunit of retromer that in turn is required for FAM21 recruitment to 
endosomes, also led to loss of COMMD1 puncta (Supplemental 
Figure S9C). Conversely, FAM21 localization was unaffected in 
CCDC22 T17A fibroblasts (Figure 5B); instead, there were dramatic 
changes in COMMD1 localization, with loss of endosomal-localized 
COMMD1 and its redistribution with a more diffuse cytosolic and 
nuclear pattern in these cells. Taken together, these data indicated 
that FAM21 is required for the recruitment of the CCC complex to 
the endosome, a process that in turn also depends on CCDC22 
expression.
To demonstrate the functional significance of these events, we 
deleted CCDC93 in HeLa cells using the CRISPR/Cas9 system. De-
letion of CCDC93 led to concurrent depletion of CCDC22 (Supple-
mental Figure S10A), as well as diffuse localization of ATP7A at both 
low- and high-copper conditions (Figure 5C, left), confirming once 
more that the CCC complex is required for copper-dependent relo-
calization of ATP7A. In control HeLa cells, peripheral vesicles con-
taining ATP7A frequently colocalized with VPS35 and COMMD1 
(Figure 5C, right). However, upon loss of CCDC93, ATP7A contin-
ued to be present in VPS35+ vesicles, but COMMD1 no longer co-
localized with ATP7A, consistent with the loss of endosomal localiza-
tion of COMMD1 observed upon depletion of CCDC22 (also noted 
in CCDC22 T17A fibroblasts in Figure 5B). Thus these data indicate 
that the loss of endosomal localization of the CCC complex is as-
sociated with altered cargo sorting.
The carboxy-terminal ends of CCDC22/CCDC93 
are responsible for FAM21 binding
Given the importance of FAM21 in the endosomal targeting of the 
CCC complex, we next turned our attention to the mechanism 
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FIGURE 5: FAM21 recruits the CCC complex to endosomes, and this is necessary for ATP7A trafficking. (A) Formation 
of cytosolic puncti of FAM21, COMMD1, CCDC93, and C16orf62 was assessed by immunofluorescence staining after 
stable silencing of FAM21 (shFAM21). Average number of puncta per cell (of ∼75 imaged cells) for the indicated CCC 
complex member. Representative images, including EEA1 staining to show the localization of early endosomes. Scale 
bar, 5 μm. (B) Endogenous COMMD1 (red) and FAM21 (green) localization was evaluated by immunofluorescence 
staining in control fibroblasts and fibroblasts derived from patients with the CCDC22 T17A mutation, as indicated. Scale 
bar, 5 μm. (C) Localization of ATP7A (red) in control and CCDC93 deleted cells (CRISPR 93). Localization of retromer 
(VPS35, green) and the CCC complex (COMMD1, purple) in cytosolic vesicles and their relative colocalization are also 
depicted. Scale bar, 10 μm. (D, E) The indicated HA­tagged CCDC93 or CCDC22 construct was transfected into 
HEK293T cells and subsequently immunoprecipitated with anti­FAM21 or control immunoglobulin G (IgG). Associated 
proteins were identified by immunoblotting with anti­HA. Note that the CCDC93 1–430 fragment was also detected in 
the IgG immunoprecipitation, indicating that this interaction with FAM21 is likely nonspecific (marked by an arrowhead).
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which is in line with the intracellular accumu-
lation of copper noted in CCDC22-deficient 
cells. These findings are in agreement with 
the recent report that retromer, acting in 
conjunction with SNX27, is required for 
ATP7A trafficking to the plasma membrane 
(Steinberg et al., 2013) and indicate that the 
CCC complex is required to facilitate this 
route of ATP7A trafficking (Figure 7C) or is 
involved in the recycling of internalized re-
ceptor back to the plasma membrane.
Furthermore, it is also evident that both 
retromer and the CCC complex are also re-
quired for the retrograde transport of ATP7A 
to the TGN under low-copper conditions, 
and the absence of VPS35 or CCC compo-
nents results in a similar phenotype of pe-
ripheral dispersal of the transporter (Figure 
7C). Prior studies indicate that the retro-
grade transport of ATP7A is also controlled 
by a number of additional complexes, in-
cluding the clathrin adaptors AP-1 and AP-2 
(Ishizaki et al., 2010; Holloway et al., 2013; 
Martinelli et al., 2013) and the BLOC-1 com-
plex (Ryder et al., 2013). Additional work will 
be required to precisely position how these 
differing systems act in sequential or parallel 
pathways to achieve this process. Further-
more, the dual effects of retromer and the 
CCC complex under high- and low-copper 
conditions imply that factors such as SNX27 
and perhaps others are needed to switch 
the directionality of ATP7A endosomal traf-
ficking in response to copper availability.
Although this work uncovers the cellular 
mechanism for the role of COMMD1 in cop-
per homeostasis, it remains unclear why hu-
mans and mice do not replicate the pheno-
type noted in dogs deficient for COMMD1. 
Liver-specific deletion of Commd1 in mice 
leads to demonstrable copper accumulation 
under high-copper diets but to an extent 
that does not induce liver injury (Vonk et al., 
2011). We studied the status of copper stores in a family with 
CCDC22 deficiency, and other than increased serum ceruloplasmin 
levels in some probands, we did not find any suggestion of copper 
toxicosis. This is consistent with prior genetic studies that failed to 
demonstrate a role for COMMD1 as a cause for non-Wilsonian cop-
per toxicosis or as a modifier of Wilson’s disease in humans (Muller 
et al., 2003; Stuehler et al., 2004; Lovicu et al., 2006). The explana-
tion for the organism-specific differences in liver pathology remains 
unclear but is in line with the substantial physiological differences in 
copper metabolism among mammals (Wang et al., 2011), which 
may highlight adaptive changes driven by dietary exposure to cop-
per. In addition, it is noteworthy that dietary factors are known to 
affect the penetrance of non-Wilsonian copper toxicosis (Shim and 
Harris, 2003; Harvey and McArdle, 2008), and it may not be ruled 
out that under certain environmental conditions, mutations in this 
pathway could result in overt clinical phenotypes.
Our studies identify that the core composition of the CCC com-
plex includes COMMD proteins in association with CCDC22, 
CCDC93, and C16orf62. This is in agreement with a prior report that 
the precise mechanism by which COMMD1 regulates copper trans-
port has remained unclear. The present study provides a mechanis-
tic framework to understand how COMMD1 affects intracellular 
copper levels. Consistent with prior work that suggested a possible 
endosomal localization and activity for COMMD1 (Burkhead et al., 
2009), we found that this factor, in conjunction with CCDC22, 
CCDC93, and C16orf62, forms a novel complex that interacts with 
the WASH complex and is required for the copper-dependent traf-
ficking of ATP7A (Figure 7C).
The copper-dependent trafficking of ATP7A is a complex pro-
cess that is incompletely understood. Under low-copper conditions, 
the transporter resides in the TGN, and upon copper excess, it is 
mobilized to cytosolic endosomal vesicles through a process that 
requires ATOX1, a chaperone protein responsible for copper deliv-
ery to these transporters (Hamza et al., 2003; Yi and Kaler, 2014). 
From these peripheral endosomal vesicles, ATP7A can then reach 
the plasma membrane to deliver copper to the extracellular space. 
Deficiency of the CCC complex or the retromer subunit VPS35 led 
in both cases to reduced plasma membrane translocation of ATP7A, 
FIGURE 6: CCDC93 interacts directly with the FAM21 tail. (A) Diagram of the fragments of 
FAM21 tail used in the in vitro binding studies. Black bars in the diagram indicate the location of 
leucine–phenylalanine acidic motifs in the tail of FAM21. (B) The indicated HA­YFP­FAM21 
suppression/reexpression vectors were transfected into HEK293T cells and subsequently 
immunoprecipitated with anti­HA. Associated CCC complex components were detected by 
immunoblotting. (C) The indicated GST­FAM21 fragments were incubated with MBP­CCDC93 
and stained for Coomassie or immunoblotted for MBP after GSH­agarose pull down. MBP­
CCDC93 is denoted by an arrowhead. (D) The GST­FAM21 356–600 protein was incubated with 
the indicated MBP­CCDC93 fragments, and interactions were detected by Coomassie staining 
after GSH­agarose pull down. (E) The indicated concentrations of MBP­CCDC93 were assessed 
for binding with GST­FAM21 306­600 using surface plasmon resonance.
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involved in receptor trafficking from mem-
brane regions where the WASH complex 
localizes.
Although our studies were focused on 
ATP7A trafficking, it is reasonable to specu-
late that this complex might regulate more 
broadly other WASH- and retromer-depen-
dent trafficking events. Indeed, we demon-
strate that the retrograde trafficking of TGN46 
back to the TGN is dependent not only on 
retromer but also on the CCC complex. Fur-
thermore, the human and Drosophila interac-
tion network maps support the notion that 
the CCC complex is closely interconnected 
with the WASH complex. In agreement with 
this interpretation, a recent study reported 
that the WASH complex coevolved in a con-
served module with the CCC complex, hav-
ing a much closer evolutionarily relationship 
with CCC than with retromer itself (Li et al., 
2014b). Additional inspection of the interac-
tion network maps also suggests that the 
CCC complex, through its putative interac-
tion with the BLOC-1, exocyst, and WAVE 
complexes, may be involved in processes 
outside of endosomal sorting such as lyso-
some biogenesis, exocytosis, and plasma 
membrane dynamics. All of these will be 
important areas to explore in future studies. 
In fact, recent studies have uncovered that 
the WASH complex is recruited to the BLOC-1 
complex, in agreement with a possible inter-
play of the CCC complex in these processes 
(Ryder et al., 2013). Finally, one critical ques-
tion that remains to be addressed is the rea-
son for the conservation of 10 COMMD 
genes in most eukaryotes. It is noteworthy 
that COMMD proteins also demonstrate an 
interdependence, suggesting that their abil-
ity to heterodimerize (Burstein et al., 2005) is 
critical to their biological function. Although 
the specific contribution that each COMMD 
protein makes in receptor trafficking remains 
obscure, it is tempting to speculate that indi-
vidual members of this family may differen-
tially regulate cargo specificity or subcellular 
localization of the complex or affect distinct 
aspects of the receptor trafficking process.
In summary, this study uncovers the mechanism by which 
COMMD1 regulates copper metabolism and identifies its essen-
tial role in the stable assembly of the CCC complex, an evolu-
tionarily conserved module that is linked to the WASH complex. 
Given the large number of endosomal cargoes regulated 
by WASH and retromer, it can be anticipated that the CCC 
complex participates in a variety of additional physiological and 
disease processes, as evident by the complex developmental 
phenotype resulting from CCDC22 mutations (Voineagu et al., 
2012; Starokadomskyy et al., 2013). Thus future work aimed 
at deciphering the actions of the CCC complex and its role in 
regulating WASH-dependent receptor trafficking should pro-
vide mechanistic insight that will have broad biomedical 
implications.
identified CCDC22 and CCDC93 as FAM21-interacting proteins 
(Harbour et al., 2012) and a more recent report that CCDC22 and 
CCDC93 are unstable when either component is depleted by siRNA 
(Freeman et al., 2014). We also delineated the domains that mediate 
the assembly of the CCC complex and demonstrated that a minimal 
CCDC93 fragment (448–631) could directly interact with a proximal 
FAM21 tail fragment (356–600). Although the data also indicated 
that the carboxyl terminus of CCDC22 could interact with FAM21 
independently of CCDC93, it remains to be established whether this 
is also a direct protein–protein interaction. Moreover, we show that 
CCDC22, CCDC93, and C16orf62 protein stability also depends on 
the presence of COMMD1 and that the CCC complex is not re-
cruited to endosomes in the absence of FAM21, further implicating 
the FAM21 unstructured tail as a recruitment node for proteins 
FIGURE 7: Endosomal targeting of the CCC complex is required for ATP7A regulation. 
(A, B) ATP7A localization (red) under low­copper conditions was examined in CCDC93­deleted 
cells (CRISPR 93), which were rescued with an empty vector (YFP), full­length CCDC93 (WT), or a 
truncation mutant unable to bind FAM21 (1–438). In addition to ATP7A, cells were stained for 
COMMD1 (purple). (A) Representative images. (B) Quantitation of ATP7A distribution (in 
30 transfected cells from each construct). Scale bar, 10 μm. (C) Model depicting the trafficking 
of ATP7A, the organization of CCC complex components, and its interaction with the WASH 
complex through FAM21.
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plasmids pEBB-AcGFP1, pEBB-E2Crimson, and pEBB-mOrange2 
were generated by PCR amplification of the corresponding coding 
sequences and insertion into the BamHI site of pEBB. Directed sub-
cloning was used to generate the constructs for fluorescent fusions 
of COMMD1, CCDC22, CCDC93, and C16orf62. These constructs 
were transfected in HEK293T cells using calcium phosphate as a 
transfection method (Maine et al., 2009) or into HeLa cells using X-
treme Gene HP DNA transfection reagent (Roche, Indianapolis, IN). 
pCI2.F.YFP constructs expressing CCDC93 wild type and CCDC93 
1–438 were generated using standard molecular biology techniques. 
RNA interference with siRNA was performed using siRNA duplexes 
obtained from (Sigma-Aldrich, St. Louis, MO; Supplemental 
Table S1). Transfection of siRNA in HEK293T cells was performed 
using calcium phosphate, and transfection in HeLa cells was per-
formed using RNAiMAX (Life Technologies). For shRNA-mediated 
silencing, the lentiviral vector pLKO.TRC vector was used with a 
standard viral vector production and selection protocol as previously 
described (Maine et al., 2007). The targeted sequences used are 
noted in Supplemental Table S1.
CRISPR/Cas9-mediated gene deletion
A HeLa cell line lacking CCDC93 was generated using an RNA 
guide sequence (GACTTTCCGGCGATGTAGCTGGG) targeting 
exon 12 and Cas9/CRISPR technology as described (Mali et al., 
2013). Clones were isolated and screened for CCDC93 expression 
by immunoblot. Gene disruption was validated by Sanger sequenc-
ing at the Gene Analysis Shared Resource, which identified an 
eight–base pair deletion within the exon 12 target (underlined in the 
guide sequence).
Biotinylation of plasma membrane proteins
Cell surface biotinylation was performed in cells using Sulfo-NHS-
SS-biotin (Pierce, Rockford, IL) in biotinylation buffer (10 mM trietha-
nolamine, 150 mM NaCl, 2 mM CaCl2, pH 8.0). Labeling was al-
lowed for 30 min at 4ºC. The biotinylated antigens were precipitated 
using NeutrAvidin agarose resin (Pierce). Precipitated protein-con-
taining beads were then resuspended in LDS sample buffer (Life 
Technologies) with 250 mM dithiothreitol (DTT). Proteins were then 
subjected to SDS–PAGE, and membranes were probed for ATP7A 
and N-Cadherin.
Protein extraction, immunoblotting, and immunoprecipitation
Cell lysate preparation, immunoprecipitation, and immunoblotting 
were performed as previously described (Burstein et al., 2004, 2005; 
Mao et al., 2009). Most immunoblotting and immunoprecipitation 
experiments were performed using a Triton X-100 lysis buffer 
(25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid [HEPES], 
100 mM NaCl, 10 mM DTT, 1 mM EDTA, 10% glycerol, 1% Triton 
X-100). Coprecipitation experiments involving WASH complex com-
ponents were performed using MRB buffer (20 mM HEPES, pH 7.2, 
50 mM potassium acetate, 1 mM EDTA, 200 mM d-sorbitol, 0.1% 
Triton X-100).
In vitro protein interaction studies
MBP and GST fusion proteins of CCDC93 and CCDC22 were gen-
erated by subcloning into pMalmut2 or pGEX-KGmut. The FAM21 
GST fusions FM, FN, and FC and HA-YFP-FAM21 suppression/
reexpression vectors were previously described (Jia et al., 2012). 
Fusion proteins were purified from E. coli BL21 (Life Technologies 
One Shot BL21 [DE3] chemically competent E. coli; 44–0048) as 
previously described (Ham et al., 2013). GST-fused proteins (40 μg) 
were bound to 40 μl of GSH agarose in 250 μl MRB buffer and 
MATERIALS AND METHODS
Human studies
All patient-related evaluation was performed with the consent of 
participating patients and their family members and was reviewed 
and approved by the pertinent institutional review boards as previ-
ously reported (Starokadomskyy et al., 2013).
Cell culture
Fibroblasts from Commd1 floxed mice, Wash floxed mice, and 
patients with the CCDC22 T17A mutation have been previously 
described (Vonk et al., 2011; Gomez et al., 2012; Starokadomskyy 
et al., 2013). HEK293T cells and HeLa cells were obtained from the 
American Type Culture Collection (Manassas, VA). All cell lines were 
maintained in high-glucose DMEM containing 10% fetal bovine se-
rum and supplemented with l-glutamine.
Copper treatments
High-copper conditions consisted of supplementing the growth me-
dium with CuCl2 to a final concentration of 200 μM for 48 h. Con-
versely, in order to examine the reversal of copper-induced traffick-
ing, low-copper conditions were established by adding 200 μM 
bathocuproine disulfonate to the growth medium for 24 h after the 
cells had been first exposed to high copper for 24 h (200 μM CuCl2).
Immunofluorescence staining
This was carried out as previously described (Gomez and Billadeau, 
2009). Cells were fixed in ice-cold fixative (4% paraformaldehyde 
and 0.5% glutaraldehyde in phosphate-buffered saline [PBS]) and 
incubated for 18 min at room temperature in the dark, followed by 
permeabilization with 0.2% Triton X-100 in PBS for 4 min. Cells were 
then incubated with 10 μg/ml primary antibodies (Abs) in IF buffer 
(Tris-buffered saline plus human serum cocktail) overnight at 4°C in a 
humidifier chamber. After three washes in PBS, cells were incubated 
with secondary Abs (1:500 dilution in blocking buffer) for 1 h at room 
temperature or overnight at 4°C in a humidifier chamber. After four 
washes in PBS and addition of Hoechst 33342 nuclear stain, cover-
slips were rinsed in water and affixed to slides with SlowFade Anti-
fade reagent (Life Technologies, Grand Island, NY). Alexa Fluor 
647–phalloidin (A22287), fluorescein isothiocyanate–phalloidin 
(F432), and rhodamine–phalloidin (R415) (Life Technologies) were 
used to visualize F-actin. Images were obtained with an LSM-710 
laser scanning confocal microscope with a 100×/1.4 oil Plan-Apo-
chromat objective lens using ZEN software (Carl Zeiss, Oberkochen, 
Germany). Mean fluorescence intensity measurements and quantita-
tive Pearson correlation coefficients were obtained using Zen 2009 
software (Carl Zeiss). Puncta enumeration was measured using the 
analyze particle tool in ImageJ (National Institutes of Health, 
Bethesda, MD). A total of 75 cells were quantified, and the data are 
displayed as the average number of puncta per cell.
Plasmids, RNA interference, transfection methods, 
and lentiviral production
The plasmids pEBB, pEBB-HA, and pEBB-HA-CCDC22 (including 
full length and the truncation mutants 1–321 and 321–627) have 
been previously described (Starokadomskyy et al., 2013). For this 
study, we PCR amplified the coding sequence of CCDC93 and 
C16orf62 from the IMAGE clones 4826022 and 6452778, respec-
tively. The various truncation mutants of CCDC22 and CCDC93 
noted in Figure 2 were generated by PCR amplification of the re-
spective coding sequences. The vectors used for short hairpin RNA 
(shRNA) suppression and reexpression of FAM21 domains have 
been previously described (Gomez and Billadeau, 2009). The 
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incubated with rotation at 4°C for 1 h and then washed once in 
MRB buffer. MBP-fused proteins or MBP were added to the aga-
rose-bound GST-CCDC22 or FAM21 tail fragments and incubated 
with rotation at 4°C for 3 h, washed twice in MRB buffer, and eluted 
in 20 μl of 4× sample loading buffer. Samples were subsequently 
run out in duplicate on 8.75% SDS–PAGE gels and stained with 
Coomassie and/or immunoblotted with anti-MBP.
Surface plasmon resonance
Surface plasmon resonance (SPR) was performed as previously de-
scribed (Dai et al., 2011). In brief, proteins for SPR were purified as 
indicated, dialyzed against Biacore buffer (10 mM HEPES, pH 7.4, 
150 mM NaCl, 0.05 mM EDTA, and 0.005% [wt/vol] polysorbate 
20) and stored at 4°C before use. GST-FAM21 FN was immobilized 
on a CM5 chip, and binding assays were performed at 25°C on a 
Biacore T200 biosensor (Biacore, Uppsala, Sweden). Biacore buffer 
containing MBP or MBP-CCDC93 (448–631) at various concentra-
tions was injected at 30 μl/min for 1 min. Bound protein was 
allowed to dissociate in Biacore buffer at 30 μl/min for 10 min and 
then desorbed with 3 M MgCl2. Binding kinetics were derived 
using BIA evaluation software (Biacore).
Antibodies
Antibodies to WASH, FAM21, and VPS35 were generated as 
previously described (Gomez and Billadeau, 2009; Jia et al., 2010). 
Antibodies to CCDC22, CCDC93, and C16orf62 were generated 
by immunizing rabbits with purified GST fusion proteins (Cocalico 
Biologicals, Reamstown, PA): CCDC22 (amino acids [aa] 432–627; 
GenBank, BC011675), CCDC93 (aa 402–631; NCBI, NM_019044.4), 
and C16orf62 (aa 73–300; NCBI, NM_020314.5). COMMD1, 
COMMD6, and COMMD9 antibodies were also generated as 
described previously (Starokadomskyy et al., 2013). The ATP7A 
antibody was obtained as a gift from Michael Petris (Biochemistry, 
University of Missouri, Columbia, MO). All other antibodies used in 
this study are listed in Supplemental Table S2.
Cellular copper measurements
Determinations of copper concentration were made by atomic ab-
sorption measurements of cellular lysates prepared as described 
previously, with minor adjustments (Vonk et al., 2011). Cell lysates 
were dissolved in HNO3:HClO4 (ratio 4:1) and incubated at 60°C for 
3 h. Copper measurements were performed with a Thermo GF95Z 
Zeeman Graphite Furnace absorption spectrometer. Copper con-
centrations were corrected for protein concentrations.
Quantitative real-time PCR
Total RNA was extracted utilizing Qiagen RNeasy kits. A Reverse 
Transcriptase kit (Life Technologies) was used to translate RNA to 
cDNA. cDNA was then subjected to real-time PCR (Mastercycler ep 
realplex2 system; Eppendorf, Hauppauge, NY) using SYBR Green 
master mix and the gene-specific primers listed in Supplemental 
Table S3.
Statistical analysis
In all cases, the mean is presented, and the error bars correspond to 
the SEM. Statistical comparisons between means were performed 
using Student’s t test with Welch’s correction (Figures 1D and 5A); 
comparisons between distributions were performed using the chi-
squared method (Figures 1B and 4, B and E).
ACKNOWLEDGMENTS
E.B. was supported by a National Institutes of Health/National Insti-
tute of Diabetes and Digestive and Kidney Diseases grant (R01 
DK073639), a Cancer Prevention Research Institute of Texas grant 
(CPRIT RP130409), and a Crohn’s & Colitis Foundation of America 
Senior Research Award (#2737). D.D.B. was supported by the Mayo 
Clinic and a National Institutes of Health/National Institute of Allergy 
and Infectious Diseases grant (R01 AI065474). The following 
National Institutes of Health training grants also supported this 
work: T32 DK007745 to A.S., T32 CA148073 to C.A.P.-K., and T32 
AI07047 to D.G.O. Z.D. was supported by the Reserve Talent of 
Universities Overseas Research Program of Heilongjiang. The Gene 
Analysis Shared Resource was supported in part by Mayo Clinic 
Comprehensive Cancer Center Support Grant P30CA15083. We are 
grateful to Michael Petris for providing the ATP7A antibody.
Volume 26 January 1, 2015 CCC complex and ATP7A trafficking | 103 
and its cargo phosphatidylinositol-4-kinase type IIα. Mol Biol Cell 24, 
2269–2284.
Schou KB, Andersen JS, Pedersen LB (2014). A divergent calponin homol-
ogy (NN-CH) domain defines a novel family: implications for evolution 
of ciliary IFT complex B proteins. Bioinformatics 30, 899–902.
Seaman MN, McCaffery JM, Emr SD (1998). A membrane coat complex es-
sential for endosome-to-Golgi retrograde transport in yeast. J Cell Biol 
142, 665–681.
Shim H, Harris ZL (2003). Genetic defects in copper metabolism. J Nutr 133, 
1527S–1531S.
Spee B, Arends B, van Wees AM, Bode P, Penning LC, Rothuizen J (2007). 
Functional consequences of RNA interference targeting COMMD1 in a 
canine hepatic cell line in relation to copper toxicosis. Anim Genet 38, 
168–170.
Starokadomskyy P, Gluck N, Li H, Chen B, Wallis M, Maine GN, Mao X, Zaidi 
IW, Hein MY, McDonald FJ, et al. (2013). CCDC22 deficiency in humans 
blunts activation of proinflammatory NF-kB signaling. J Clin Invest 123, 
2244–2256.
Steinberg F, Gallon M, Winfield M, Thomas EC, Bell AJ, Heesom KJ, Tavare 
JM, Cullen PJ (2013). A global analysis of SNX27-retromer assembly and 
cargo specificity reveals a function in glucose and metal ion transport. 
Nat Cell Biol 15, 461–471.
Stuehler B, Reichert J, Stremmel W, Schaefer M (2004). Analysis of the hu-
man homologue of the canine copper toxicosis gene MURR1 in Wilson 
disease patients. J Mol Med 82, 629–634.
Su LC, Ravanshad S, Owen CA Jr, McCall JT, Zollman PE, Hardy RM (1982). 
A comparison of copper-loading disease in Bedlington terriers and 
Wilson’s disease in humans. Am J Physiol 243, G226–G230.
Tao TY, Liu F, Klomp L, Wijmenga C, Gitlin JD (2003). The copper toxicosis 
gene product Murr1 directly interacts with the Wilson disease protein. 
J Biol Chem 278, 41593–41596.
van de Sluis B, Mao X, Zhai Y, Groot AJ, Vermeulen JF, van der Wall E, van 
Diest PJ, Hofker MH, Wijmenga C, Klomp LW, et al. (2010). COMMD1 
disrupts HIF-1a/b dimerization and inhibits human tumor cell invasion. 
J Clin Invest 120, 2119–2130.
van de Sluis B, Muller P, Duran K, Chen A, Groot AJ, Klomp LW, Liu PP, 
Wijmenga C (2007). Increased activity of hypoxia-inducible factor 1 is 
associated with early embryonic lethality in Commd1 null mice. Mol Cell 
Biol 27, 4142–4156.
van de Sluis B, Rothuizen J, Pearson PL, van Oost BA, Wijmenga C (2002). 
Identification of a new copper metabolism gene by positional cloning in 
a purebred dog population. Hum Mol Genet 11, 165–173.
Voineagu I, Huang L, Winden K, Lazaro M, Haan E, Nelson J, McGaughran 
J, Nguyen LS, Friend K, Hackett A, et al. (2012). CCDC22: a novel can-
didate gene for syndromic X-linked intellectual disability. Mol Psychiatry 
17, 4–7.
Vonk WI, Bartuzi P, de Bie P, Kloosterhuis N, Wichers CG, Berger R, Haywood 
S, Klomp LW, Wijmenga C, van de Sluis B (2011). Liver-specific Commd1 
knockout mice are susceptible to hepatic copper accumulation. PLoS 
One 6, e29183.
Wang Y, Hodgkinson V, Zhu S, Weisman GA, Petris MJ (2011). Advances in the 
understanding of mammalian copper transporters. Adv Nutr 2, 129–137.
Weiss KH, Lozoya JC, Tuma S, Gotthardt D, Reichert J, Ehehalt R, Stremmel 
W, Fullekrug J (2008). Copper-induced translocation of the Wilson dis-
ease protein ATP7B independent of Murr1/ COMMD1 and Rab7. Am J 
Pathol 173, 1783–1794.
Yi L, Kaler S (2014). ATP7A trafficking and mechanisms underlying the distal 
motor neuropathy induced by mutations in ATP7A. Ann NY Acad Sci 
1314, 49–54.
Zech T, Calaminus SD, Caswell P, Spence HJ, Carnell M, Insall RH, Norman 
J, Machesky LM (2011). The Arp2/3 activator WASH regulates a5b1-
integrin-mediated invasive migration. J Cell Sci 124, 3753–3759.
Holloway ZG, Velayos-Baeza A, Howell GJ, Levecque C, Ponnambalam S, 
Sztul E, Monaco AP (2013). Trafficking of the Menkes copper transporter 
ATP7A is regulated by clathrin-, AP-2-, AP-1-, and Rab22-dependent 
steps. Mol Biol Cell 24, 1735–1748, S1–S8.
Ishizaki H, Spitzer M, Wildenhain J, Anastasaki C, Zeng Z, Dolma S, Shaw 
M, Madsen E, Gitlin J, Marais R, Tyers M, et al. (2010). Combined 
zebrafish-yeast chemical-genetic screens reveal gene-copper-nutrition 
interactions that modulate melanocyte pigmentation. Dis Models Mech 
3, 639–651.
Jia D, Gomez TS, Billadeau DD, Rosen MK (2012). Multiple repeat elements 
within the FAM21 tail link the WASH actin regulatory complex to the 
retromer. Mol Biol Cell 23, 2352–2361.
Jia D, Gomez TS, Metlagel Z, Umetani J, Otwinowski Z, Rosen MK, Billadeau 
DD (2010). WASH and WAVE actin regulators of the Wiskott-Aldrich 
syndrome protein (WASP) family are controlled by analogous structurally 
related complexes. Proc Natl Acad Sci USA 107, 10442–10447.
Kolanczyk M, Krawitz P, Hecht J, Hupalowska A, Miaczynska M, Marschner 
K, Schlack C, Emerich D, Kobus K, Kornak U, et al. (2014). Missense 
variant in CCDC22 causes X-linked recessive intellectual disability 
with features of Ritscher-Schinzel/3C syndrome. Eur J Hum Genet, doi 
10.1038/ejhg.2014.109.
Li Y, Calvo SE, Gutman R, Liu JS, Mootha VK (2014b). Expansion of biologi-
cal pathways based on evolutionary inference. Cell 158, 213–225.
Li H, Chan L, Bartuzi P, Melton SD, Weber A, Ben-Shlomo S, Varol C, Raetz 
M, Mao X, Starokadomskyy P, et al. (2014a). Copper metabolism 
domain-containing 1 represses genes that promote inflammation and 
protects mice from colitis and colitis-associated cancer. Gastroenterology 
147, 184–195.
Lovicu M, Dessi V, Lepori MB, Zappu A, Zancan L, Giacchino R, Marazzi MG, 
Iorio R, Vegnente A, Vajro P, et al. (2006). The canine copper toxicosis 
gene MURR1 is not implicated in the pathogenesis of Wilson disease. 
J Gastroenterol 41, 582–587.
Maine GN, Gluck N, Zaidi IW, Burstein E (2009). Bimolecular affinity purifica-
tion (BAP): tandem affinity purification using two protein baits. Cold 
Spring Harb Protoc 10.1101/pdb.prot5318.
Maine GN, Mao X, Komarck CM, Burstein E (2007). COMMD1 promotes the 
ubiquitination of NF-kB subunits through a Cullin-containing ubiquitin 
ligase. EMBO J 26, 436–447.
Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church 
GM (2013). RNA-guided human genome engineering via Cas9. Science 
339, 823–826.
Mao X, Gluck N, Li D, Maine GN, Li H, Zaidi IW, Repaka A, Mayo MW, 
Burstein E (2009). GCN5 is a required cofactor for a ubiquitin ligase that 
targets NF-kB/RelA. Genes Dev 23, 849–861.
Martinelli D, Travaglini L, Drouin CA, Ceballos-Picot I, Rizza T, Bertini E, 
Carrozzo R, Petrini S, de Lonlay P, El Hachem M, et al. (2013). MED-
NIK syndrome: a novel defect of copper metabolism treatable by zinc 
acetate therapy. Brain 136, 872–881.
Materia S, Cater MA, Klomp LW, Mercer JF, La Fontaine S (2012). Clusterin 
and COMMD1 independently regulate degradation of the mammalian 
copper-ATPases ATP7A and ATP7B. J Biol Chem 287, 2485–2499.
Miyayama T, Hiraoka D, Kawaji F, Nakamura E, Suzuki N, Ogra Y (2010). 
Roles of COMM-domain-containing 1 in stability and recruitment of 
the copper-transporting ATPase in a mouse hepatoma cell line. Bio-
chem J 429, 53–61.
Muller T, van de Sluis B, Zhernakova A, van Binsbergen E, Janecke AR, 
Bavdekar A, Pandit A, Weirich-Schwaiger H, Witt H, Ellemunter H, et al. 
(2003). The canine copper toxicosis gene MURR1 does not cause non-
Wilsonian hepatic copper toxicosis. J Hepatol 38, 164–168.
Ryder PV, Vistein R, Gokhale A, Seaman MN, Puthenveedu MA, Faun-
dez V (2013). The WASH complex, an endosomal Arp2/3 activator, 
interacts with the Hermansky–Pudlak syndrome complex BLOC-1 
Supplemental Materials 
Molecular Biology of the Cell
 
 Phillips-Krawczak  et al.
 
 
 
ATP7A / GM130 / Nuclei
Control
Low Cu High Cu Low Cu High Cu
CCDC22 T17A
Figure S1
Figure S1. Role of CCDC22 in ATP7A localization. ATP7A localization in response to copper treatment 
was evaluated in control and CCDC22 T17A mutant fibroblasts. Scale bar = 20 m. 
Gene Identity (%)
Species Symbol Protein DNA
H.sapiens C16orf62
vs. P.troglodytes C16H16orf62 98.8 98.9
vs. M.mulatta LOC695027 98.1 97.5
vs. C.lupus C6H16orf62 96.6 92.0
vs. B.taurus C25H16orf62 96.9 91.9
vs. M.musculus 9030624J02Rik 92.3 86.2
vs. R.norvegicus LOC361635 93.7 87.6
vs. G.gallus C14H16orf62 86.3 77.1
vs. D.rerio zgc:163107 74.0 69.2
vs. D.melanogaster CG8202 44.7 52.1
vs. A.gambiae AgaP_AGAP001150 48.9 53.5
vs. C.elegans CELE_F26G1.1 24.1 39.0
vs. A.thaliana AT1G50730 25.5 42.6
Gene Identity (%)
Species Symbol Protein DNA
H.sapiens CCDC93
vs. M.mulatta LOC694513 98.8 98.5
vs. C.lupus CCDC93 95.4 91.9
vs. B.taurus CCDC93 93.8 90.4
vs. M.musculus Ccdc93 92.1 86.8
vs. R.norvegicus Ccdc93 93.0 86.7
vs. G.gallus CCDC93 80.8 75.3
vs. D.rerio ccdc93 70.9 67.6
vs. D.melanogaster fidipidine 41.7 50.2
vs. A.gambiae AgaP_AGAP009044 44.4 52.9
vs. C.elegans C16A11.2 24.3 39.3
vs. A.thaliana AT4G32560 30.4 44.5
Gene Identity (%)
Species Symbol Protein DNA
H.sapiens CCDC22
vs. P.troglodytes CCDC22 100.0 99.6
vs. M.mulatta CCDC22 98.4 98.1
vs. C.lupus CCDC22 91.5 89.6
vs. B.taurus CCDC22 90.9 90.1
vs. M.musculus Ccdc22 88.0 85.7
vs. R.norvegicus Ccdc22 87.9 85.7
vs. D.rerio ccdc22 58.0 61.1
vs. D.melanogaster CG9951 30.6 44.9
vs. A.gambiae CCDC22_ANOGA 38.8 51.0
vs. A.thaliana AT1G55830 34.0 44.3
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Figure S2. Conservation of CCC complex components. (A-C). Protein and DNA sequence identity from 
various organisms compiled from NCBI HomoloGene Pairwise Alignment Scores.  CCDC22, CCDC93 and 
C16orf62 are displayed.
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Figure S3. CCC complex shows interdependency for complex stability. (A) Binding to CCDC93 was 
evaluated by expressing COMMD proteins fused to GST in HEK293T cells.  The proteins were subsequently 
precipitated from Triton X-100 lysates and the recovered material was immunoblotted for endogenous 
CCDC93 or GST.  PD, pulldown. (B, C) Protein and RNA was isolated from HeLa cells transfected with 
either control siRNA or siRNA toward CCDC22 or CCDC93. Subsequently, western blot analysis (B) and 
qRT-PCR (C)  was performed to determine the effect on CCDC22 and CCDC93 expression. 
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Figure S4. Interactions that mediate CCC complex assembly. (A) In vitro interactions between E. coli
generated recombinant CCDC22 and CCDC93 fragments was assessed. After precipitation of GST-
CCDC22, the presence of co-precipitated MBP-CCDC93 was determined by Coomassie staining and by 
immunoblotting. (B) CCDC93 was silenced in HEK293T cells using two independent siRNA duplexes. 
Subsequently, CCDC22 was immunoprecipitated and interactions with other CCC components were 
assessed by immunoblotting. (C) C16orf62 was silenced by siRNA in HEK293T cells. Subsequently, 
CCDC93 was immunoprecipitated and co-precipitated proteins were detected by immunoblotting. 
CCC 
COMPLEX
COMMD
Proteins
Figure S5
Drosophila
FAM21
Vps35
Snx1Snx6
Abi
Nup62 Nup88
CG10510
(CCDC65L)
Blos2
Dtnbp1
WAVE  COMPLEX
BLOC-1
Vps29
WASH COMPLEX
RETROMER COMPLEX EXOCYST COMPLEX 
10
Exoc1
CCDC53
WASH
Exoc8
Exoc7
CCDC93CCDC22
CG32809
Vps26
Figure S5. CCC complex Drosophila interaction map. Interaction maps between CCC complex 
components and other cellular complexes were drawn using data extracted from NCBI. Intra-complex 
interactions, where useful, were also indicated.
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Figure S6. CCC complex interactions do not require retromer or WASH complex. (A) Coprecipitation
between CCC complex components, as well as the WASH complex subunit WASH1.  The coiled-coil protein 
NEMO, and it’s known interacting partner IKK1, are included as additional controls.  (B) HeLa cell lysates were 
immunoprecipitated and immunoblotted as indicated to assess CCC complex interactions with FAM21.  (C,D)
Cell lysates from the indicated cell lines were used for immunoprecipitation and immunoblotting analysis to 
assess CCC interactions in the absence of retromer (C, using HeLa cells expressing shRNA targeting VPS35) 
or WASH (D, using Wash-deficient fibroblasts). (E) Interactions between CCDC93 and its partners CCDC22 
and C16orf62 were assessed by co-immunoprecipitation in control and FAM21-depleted HeLa cells. 
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Figure S7. CCC complex localizes to distinct endosomal compartments enriched in WASH and 
Retromer. (A) Commd1 deficient (Commd1-/-) and isogenic control fibroblasts were stained for COMMD1 
(green) and nuclei (blue) and imaged by confocal microscopy (scale bar of 10 m). (B, C) Co-localization of 
endogenous COMMD1 (green) and various vesicular markers, as indicated, was assessed by 
immunofluorescence staining of HeLa cells (scale bar of 5 m). Representative images are shown (B) and 
co-localization coefficients were calculated and plotted based on these images as well as those in Figure 
3C,D (C). (D) Live cell imaging of HeLa cells transiently expressing the indicated fluorescent proteins depicts 
the co-localization of CCC complex components. Scale bar = 5 m. 
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Figure S8
Figure S8. Effects of CCC deficiency on ATP7A protein expression. (A) HeLa cells were transfected 
with the indicated siRNA oligonucleotides and the expression levels of ATP7A were ascertained by 
immunoblot.  (B) ATP7A levels in fibroblasts derived from 2 control individuals (WT) and two patients with 
the CCDC22 T17A mutation.  (C) ATP7A levels in cell lines with stable silencing of the indicated genes.  
Only VPS35 depletion led to significant effects on ATP7A expression levels.  (D) ATP7A levels in the 
indicated cells lines were evaluated under conditions of high and low copper availability in the media.
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Figure S9. CCC complex localizes to endosomes with FAM21. (A) Enlarged images from Figure 5A 
showing only staining for the indicated proteins in the control and shFAM21-depleted HeLa cell lines. Scale 
bar = 5 m. (B) WASH-deficient (Wash-/-) and isogenic control fibroblasts were stained with anti-COMMD1 
antibody (green), anti-FAM21 (red) and nuclei (blue) and imaged by confocal microscopy.Scale bar = 10 m. 
(C) HeLa scramble control and shVPS35 cells were mixed 1:1, plated on coverslips and stained as 
indicated. Scale bar = 5 m.
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Figure S10
Figure S10. (A) CRISPR/Cas9 mediated deletion of CCDC93 in HeLa cells. Loss of CCDC93 expression is 
shown by WB, which also demonstrates the concurrent reduction in CCDC22 expression. (B) Control SPR 
experiment.  The indicated concentrations of MBP or MBP-CCDC93 were assessed for binding with GST-FAM21-
FN using SPR. (C) Low magnification images of the CRISPR-93 HeLa line transfected with YFP vector or YFP-
CCDC93 wild type or 1-438 mutant and imaged for ATP7A and COMMD1 localization under low copper 
conditions. Scale bar = 10m. 
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Figure S11
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Figure S11. (A, B) The indicated domains of CCDC22 (A) and CCDC93 (B) were expressed in 
293 cells. Subsequently, cell lysates were subjected to immunoprecipitation with control IgG or an 
antibody against NEMO.  IKK1 is a known partner of NEMO and serves as a positive control.   
Table S1: siRNA and shRNA sequences utilized 
siRNA sequences 
Gene target (human) Oligo sequence 
CCDC22# 1 CCACUGAGCUGGUUGUAGA 
CCDC22 # 2 CCAAGACUGGUGCUCCUAA 
CCDC93 # 1 CCGUAUAUCACCUACAAGA 
CCDC93# 2 GAUUGUGUCCGAGUAUGCA 
C16orf62 # 1 GAGAAAUCCUUGCCCGGUA 
C16orf62 # 2 GAUCCUAGAGCAUCUGAAA 
shRNA sequences  
Gene target (human) shRNA sequence 
CCDC22 GATGAGCTTGTGTTCAAGGAT 
CCDC93 GACCTAGACAGACGGTATAAT 
C16orf62 GCCTGTTCTTGTGCAGTTGAT 
   FAM21 CCCCACAGCAAACCTTCTAAA 
VPS35 AACAGAGCAGATTAACAAACA 
 
Table S2: Antibodies utilized 
 
Target protein Supplier Cat. No. 
GM130 BD Transduction labs 610822 
CCDC22 ProteinTech Group 16636-1-AP 
CCDC93 ProteinTech Group 20861-1-AP 
C16orf62 Pierce PA5-28553 
COMMD1 R & D systems MAB7526 
VPS35 AbCam ab10099-199 
EEA1 BD Biosciences 610456 
APPL1 Cell Signaling Technology 3858S 
RUFY1 ProteinTech Group 13498-1-AP 
LAMP1 AbCam ab24170 
TGN46 Sigma Aldrich T7576 
β-Actin Sigma Aldrich A5441 
HA Covance MMS101R 
MBP Immuno Consultants Lab RMBP45-A-Z 
GST Santa Cruz Sc-459 
N-cadherin BD Biosciences 610920 
 
Table S3: Primers utilized for qRT-PCR (human genes) 
 
Target Sense primer Antisense primer 
CCDC93 AGGCTTATCACCCTTTGACAAG GGCAGGACCGAGACAATTTTT 
CCDC22 CTATCAGAACTTCCTCTACCC GGAGAATAGCTGAGTCACCT 
ACTB GCGGGAAATCGTGCGTGACATT GATGGAGTTGAAGGTAGTTTCGTG 
  
 
